| Title: |
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement |
| Authors: |
The ARIA-MASK study group; Klimek, Ludger; Jutel, Marek; Akdis, Cezmi; Haahtela, Tari; Toppila-Salmi, Sanna; Zuberbier, Torsten |
| Contributors: |
Department of Dermatology, Allergology and Venereology; HUS Inflammation Center; Department of Pathology |
| Publisher Information: |
Wiley Blackwell |
| Publication Year: |
2021 |
| Collection: |
Helsingfors Universitet: HELDA – Helsingin yliopiston digitaalinen arkisto |
| Subject Terms: |
General medicine; internal medicine and other clinical medicine; allergy treatment; clinical immunotherapy; immunotherapy vaccines and mechanisms; VENOM ALLERGY; ASTHMA; MECHANISMS; VACCINES |
| Description: |
The current COVID-19 pandemic influences many aspects of personal and social interaction, including patient contacts with health care providers and the manner in which allergy care is provided and maintained. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on inducing an appropriate immune response in the allergic patient. This manuscript outlines the EAACI recommendations regarding AIT during the COVID-19 pandemic and aims at supporting allergists and all physicians performing AIT in their current daily practice with clear recommendations on how to perform treatment during the pandemic and in SARS-CoV-2 infected patients. ; Peer reviewed |
| Document Type: |
article in journal/newspaper |
| File Description: |
application/pdf |
| Language: |
English |
| Relation: |
RIS: urn:407DBAC1B6216DD6BEA5AFDA918C6F60; https://hdl.handle.net/10138/329361; 000562838200001 |
| Availability: |
https://hdl.handle.net/10138/329361 |
| Rights: |
unspecified ; info:eu-repo/semantics/openAccess ; openAccess |
| Accession Number: |
edsbas.C8AFEAA0 |
| Database: |
BASE |